img

Global Angiotensin Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Angiotensin Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
Angiotensin Receptor Antagonists report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angiotensin Receptor Antagonists market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hypertension and Cardiovascular Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angiotensin Receptor Antagonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angiotensin Receptor Antagonists key manufacturers include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. Pfizer, Novartis, Merck are top 3 players and held % sales share in total in 2022.
Angiotensin Receptor Antagonists can be divided into Valsartan, Telmisartan, Losartan and Irbesartan, etc. Valsartan is the mainstream product in the market, accounting for % sales share globally in 2022.
Angiotensin Receptor Antagonists is widely used in various fields, such as Hypertension, Cardiovascular Diseases, Kidney Diseases and Other, etc. Hypertension provides greatest supports to the Angiotensin Receptor Antagonists industry development. In 2022, global % sales of Angiotensin Receptor Antagonists went into Hypertension filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angiotensin Receptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan

Segment by Application


Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Angiotensin Receptor Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angiotensin Receptor Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angiotensin Receptor Antagonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Angiotensin Receptor Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angiotensin Receptor Antagonists introduction, etc. Angiotensin Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Angiotensin Receptor Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Angiotensin Receptor Antagonists Market Overview
1.1 Angiotensin Receptor Antagonists Product Overview
1.2 Angiotensin Receptor Antagonists Market Segment by Type
1.2.1 Valsartan
1.2.2 Telmisartan
1.2.3 Losartan
1.2.4 Irbesartan
1.2.5 Azilsartan
1.2.6 Olmesartan
1.3 Global Angiotensin Receptor Antagonists Market Size by Type
1.3.1 Global Angiotensin Receptor Antagonists Market Size Overview by Type (2018-2034)
1.3.2 Global Angiotensin Receptor Antagonists Historic Market Size Review by Type (2018-2024)
1.3.3 Global Angiotensin Receptor Antagonists Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Angiotensin Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.2 Europe Angiotensin Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Angiotensin Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Angiotensin Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Angiotensin Receptor Antagonists Sales Breakdown by Type (2018-2024)
2 Global Angiotensin Receptor Antagonists Market Competition by Company
2.1 Global Top Players by Angiotensin Receptor Antagonists Sales (2018-2024)
2.2 Global Top Players by Angiotensin Receptor Antagonists Revenue (2018-2024)
2.3 Global Top Players by Angiotensin Receptor Antagonists Price (2018-2024)
2.4 Global Top Manufacturers Angiotensin Receptor Antagonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 Angiotensin Receptor Antagonists Market Competitive Situation and Trends
2.5.1 Angiotensin Receptor Antagonists Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Angiotensin Receptor Antagonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2022)
2.7 Date of Key Manufacturers Enter into Angiotensin Receptor Antagonists Market
2.8 Key Manufacturers Angiotensin Receptor Antagonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Angiotensin Receptor Antagonists Status and Outlook by Region
3.1 Global Angiotensin Receptor Antagonists Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Angiotensin Receptor Antagonists Historic Market Size by Region
3.2.1 Global Angiotensin Receptor Antagonists Sales in Volume by Region (2018-2024)
3.2.2 Global Angiotensin Receptor Antagonists Sales in Value by Region (2018-2024)
3.2.3 Global Angiotensin Receptor Antagonists Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Angiotensin Receptor Antagonists Forecasted Market Size by Region
3.3.1 Global Angiotensin Receptor Antagonists Sales in Volume by Region (2024-2034)
3.3.2 Global Angiotensin Receptor Antagonists Sales in Value by Region (2024-2034)
3.3.3 Global Angiotensin Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Angiotensin Receptor Antagonists by Application
4.1 Angiotensin Receptor Antagonists Market Segment by Application
4.1.1 Hypertension
4.1.2 Cardiovascular Diseases
4.1.3 Kidney Diseases
4.1.4 Other
4.2 Global Angiotensin Receptor Antagonists Market Size by Application
4.2.1 Global Angiotensin Receptor Antagonists Market Size Overview by Application (2018-2034)
4.2.2 Global Angiotensin Receptor Antagonists Historic Market Size Review by Application (2018-2024)
4.2.3 Global Angiotensin Receptor Antagonists Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Angiotensin Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.2 Europe Angiotensin Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Angiotensin Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Angiotensin Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Angiotensin Receptor Antagonists Sales Breakdown by Application (2018-2024)
5 North America Angiotensin Receptor Antagonists by Country
5.1 North America Angiotensin Receptor Antagonists Historic Market Size by Country
5.1.1 North America Angiotensin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Angiotensin Receptor Antagonists Sales in Volume by Country (2018-2024)
5.1.3 North America Angiotensin Receptor Antagonists Sales in Value by Country (2018-2024)
5.2 North America Angiotensin Receptor Antagonists Forecasted Market Size by Country
5.2.1 North America Angiotensin Receptor Antagonists Sales in Volume by Country (2024-2034)
5.2.2 North America Angiotensin Receptor Antagonists Sales in Value by Country (2024-2034)
6 Europe Angiotensin Receptor Antagonists by Country
6.1 Europe Angiotensin Receptor Antagonists Historic Market Size by Country
6.1.1 Europe Angiotensin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Angiotensin Receptor Antagonists Sales in Volume by Country (2018-2024)
6.1.3 Europe Angiotensin Receptor Antagonists Sales in Value by Country (2018-2024)
6.2 Europe Angiotensin Receptor Antagonists Forecasted Market Size by Country
6.2.1 Europe Angiotensin Receptor Antagonists Sales in Volume by Country (2024-2034)
6.2.2 Europe Angiotensin Receptor Antagonists Sales in Value by Country (2024-2034)
7 Asia-Pacific Angiotensin Receptor Antagonists by Region
7.1 Asia-Pacific Angiotensin Receptor Antagonists Historic Market Size by Region
7.1.1 Asia-Pacific Angiotensin Receptor Antagonists Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Angiotensin Receptor Antagonists Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Angiotensin Receptor Antagonists Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Angiotensin Receptor Antagonists Forecasted Market Size by Region
7.2.1 Asia-Pacific Angiotensin Receptor Antagonists Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Angiotensin Receptor Antagonists Sales in Value by Region (2024-2034)
8 Latin America Angiotensin Receptor Antagonists by Country
8.1 Latin America Angiotensin Receptor Antagonists Historic Market Size by Country
8.1.1 Latin America Angiotensin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Angiotensin Receptor Antagonists Sales in Volume by Country (2018-2024)
8.1.3 Latin America Angiotensin Receptor Antagonists Sales in Value by Country (2018-2024)
8.2 Latin America Angiotensin Receptor Antagonists Forecasted Market Size by Country
8.2.1 Latin America Angiotensin Receptor Antagonists Sales in Volume by Country (2024-2034)
8.2.2 Latin America Angiotensin Receptor Antagonists Sales in Value by Country (2024-2034)
9 Middle East and Africa Angiotensin Receptor Antagonists by Country
9.1 Middle East and Africa Angiotensin Receptor Antagonists Historic Market Size by Country
9.1.1 Middle East and Africa Angiotensin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Angiotensin Receptor Antagonists Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Angiotensin Receptor Antagonists Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Angiotensin Receptor Antagonists Forecasted Market Size by Country
9.2.1 Middle East and Africa Angiotensin Receptor Antagonists Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Angiotensin Receptor Antagonists Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Angiotensin Receptor Antagonists Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis Angiotensin Receptor Antagonists Products Offered
10.2.5 Novartis Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Angiotensin Receptor Antagonists Products Offered
10.3.5 Merck Recent Development
10.4 Astra Zeneca
10.4.1 Astra Zeneca Company Information
10.4.2 Astra Zeneca Introduction and Business Overview
10.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Astra Zeneca Angiotensin Receptor Antagonists Products Offered
10.4.5 Astra Zeneca Recent Development
10.5 Jhonson and Johnson
10.5.1 Jhonson and Johnson Company Information
10.5.2 Jhonson and Johnson Introduction and Business Overview
10.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Products Offered
10.5.5 Jhonson and Johnson Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly Angiotensin Receptor Antagonists Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Angiotensin Receptor Antagonists Products Offered
10.7.5 Sanofi Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bayer Angiotensin Receptor Antagonists Products Offered
10.9.5 Bayer Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.10.4 GSK Angiotensin Receptor Antagonists Products Offered
10.10.5 GSK Recent Development
10.11 Teva Pharmaceutical
10.11.1 Teva Pharmaceutical Company Information
10.11.2 Teva Pharmaceutical Introduction and Business Overview
10.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Products Offered
10.11.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Angiotensin Receptor Antagonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Angiotensin Receptor Antagonists Industrial Chain Analysis
11.4 Angiotensin Receptor Antagonists Market Dynamics
11.4.1 Angiotensin Receptor Antagonists Industry Trends
11.4.2 Angiotensin Receptor Antagonists Market Drivers
11.4.3 Angiotensin Receptor Antagonists Market Challenges
11.4.4 Angiotensin Receptor Antagonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Angiotensin Receptor Antagonists Distributors
12.3 Angiotensin Receptor Antagonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Valsartan
Table 2. Major Company of Telmisartan
Table 3. Major Company of Losartan
Table 4. Major Company of Irbesartan
Table 5. Major Company of Azilsartan
Table 6. Major Company of Olmesartan
Table 7. Global Angiotensin Receptor Antagonists Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (K MT)
Table 9. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US& Million)
Table 11. Global Angiotensin Receptor Antagonists Market Share in Value by Type (2018-2024)
Table 12. Global Angiotensin Receptor Antagonists Price by Type (2018-2024) & (USD/MT)
Table 13. Global Angiotensin Receptor Antagonists Sales by Type (2024-2034) & (K MT)
Table 14. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Angiotensin Receptor Antagonists Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Type (2024-2034)
Table 17. Global Angiotensin Receptor Antagonists Price by Type (2024-2034) & (USD/MT)
Table 18. North America Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (K MT)
Table 19. North America Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Angiotensin Receptor Antagonists Sales (K MT) by Type (2018-2024)
Table 21. Europe Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Angiotensin Receptor Antagonists Sales (K MT) by Type (2018-2024)
Table 23. Asia-Pacific Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Angiotensin Receptor Antagonists Sales (K MT) by Type (2018-2024)
Table 25. Latin America Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Angiotensin Receptor Antagonists Sales (K MT) by Type (2018-2024)
Table 27. Middle East and Africa Angiotensin Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Angiotensin Receptor Antagonists Sales by Company (2018-2024) & (K MT)
Table 29. Global Angiotensin Receptor Antagonists Sales Share by Company (2018-2024)
Table 30. Global Angiotensin Receptor Antagonists Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Angiotensin Receptor Antagonists Revenue Share by Company (2018-2024)
Table 32. Global Market Angiotensin Receptor Antagonists Price by Company (2018-2024) & (USD/MT)
Table 33. Global Angiotensin Receptor Antagonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2022)
Table 36. Date of Key Manufacturers Enter into Angiotensin Receptor Antagonists Market
Table 37. Key Manufacturers Angiotensin Receptor Antagonists Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Angiotensin Receptor Antagonists Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Angiotensin Receptor Antagonists Sales by Region (2018-2024) & (K MT)
Table 41. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Angiotensin Receptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 44. Global Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 45. Global Angiotensin Receptor Antagonists Sales by Region (2024-2034) & (K MT)
Table 46. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Angiotensin Receptor Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Region (2024-2034)
Table 49. Global Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 50. Global Angiotensin Receptor Antagonists Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (K MT)
Table 52. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2018-2024)
Table 55. Global Angiotensin Receptor Antagonists Price by Application (2018-2024) & (USD/MT)
Table 56. Global Angiotensin Receptor Antagonists Sales by Application (2024-2034) & (K MT)
Table 57. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Angiotensin Receptor Antagonists Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2024-2034)
Table 60. Global Angiotensin Receptor Antagonists Price by Application (2024-2034) & (USD/MT)
Table 61. North America Angiotensin Receptor Antagonists Sales by Application (2018-2024) (K MT)
Table 62. North America Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Angiotensin Receptor Antagonists Sales by Application (2018-2024) (K MT)
Table 64. Europe Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Angiotensin Receptor Antagonists Sales by Application (2018-2024) (K MT)
Table 66. Asia-Pacific Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2024) (K MT)
Table 68. Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Angiotensin Receptor Antagonists Sales by Application (2018-2024) (K MT)
Table 70. Middle East and Africa Angiotensin Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 72. North America Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 75. North America Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 76. North America Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 80. Europe Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 84. Europe Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2018-2024) & (K MT)
Table 88. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2024-2034) & (K MT)
Table 92. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 96. Latin America Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 100. Latin America Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 104. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 108. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 111. Pfizer Company Information
Table 112. Pfizer Introduction and Business Overview
Table 113. Pfizer Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 114. Pfizer Angiotensin Receptor Antagonists Product
Table 115. Pfizer Recent Development
Table 116. Novartis Company Information
Table 117. Novartis Introduction and Business Overview
Table 118. Novartis Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 119. Novartis Angiotensin Receptor Antagonists Product
Table 120. Novartis Recent Development
Table 121. Merck Company Information
Table 122. Merck Introduction and Business Overview
Table 123. Merck Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 124. Merck Angiotensin Receptor Antagonists Product
Table 125. Merck Recent Development
Table 126. Astra Zeneca Company Information
Table 127. Astra Zeneca Introduction and Business Overview
Table 128. Astra Zeneca Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 129. Astra Zeneca Angiotensin Receptor Antagonists Product
Table 130. Astra Zeneca Recent Development
Table 131. Jhonson and Johnson Company Information
Table 132. Jhonson and Johnson Introduction and Business Overview
Table 133. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 134. Jhonson and Johnson Angiotensin Receptor Antagonists Product
Table 135. Jhonson and Johnson Recent Development
Table 136. Eli Lilly Company Information
Table 137. Eli Lilly Introduction and Business Overview
Table 138. Eli Lilly Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 139. Eli Lilly Angiotensin Receptor Antagonists Product
Table 140. Eli Lilly Recent Development
Table 141. Sanofi Company Information
Table 142. Sanofi Introduction and Business Overview
Table 143. Sanofi Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 144. Sanofi Angiotensin Receptor Antagonists Product
Table 145. Sanofi Recent Development
Table 146. Bristol-Myers Squibb Company Information
Table 147. Bristol-Myers Squibb Introduction and Business Overview
Table 148. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 149. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product
Table 150. Bristol-Myers Squibb Recent Development
Table 151. Bayer Company Information
Table 152. Bayer Introduction and Business Overview
Table 153. Bayer Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 154. Bayer Angiotensin Receptor Antagonists Product
Table 155. Bayer Recent Development
Table 156. GSK Company Information
Table 157. GSK Introduction and Business Overview
Table 158. GSK Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 159. GSK Angiotensin Receptor Antagonists Product
Table 160. GSK Recent Development
Table 161. Teva Pharmaceutical Company Information
Table 162. Teva Pharmaceutical Introduction and Business Overview
Table 163. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 164. Teva Pharmaceutical Angiotensin Receptor Antagonists Product
Table 165. Teva Pharmaceutical Recent Development
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Angiotensin Receptor Antagonists Market Trends
Table 169. Angiotensin Receptor Antagonists Market Drivers
Table 170. Angiotensin Receptor Antagonists Market Challenges
Table 171. Angiotensin Receptor Antagonists Market Restraints
Table 172. Angiotensin Receptor Antagonists Distributors List
Table 173. Angiotensin Receptor Antagonists Downstream Customers
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Angiotensin Receptor Antagonists Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Angiotensin Receptor Antagonists Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Valsartan
Figure 6. Global Valsartan Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Telmisartan
Figure 8. Global Telmisartan Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Losartan
Figure 10. Global Losartan Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Irbesartan
Figure 12. Global Irbesartan Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Product Picture of Azilsartan
Figure 14. Global Azilsartan Sales YoY Growth (2018-2034) & (K MT)
Figure 15. Product Picture of Olmesartan
Figure 16. Global Olmesartan Sales YoY Growth (2018-2034) & (K MT)
Figure 17. Global Angiotensin Receptor Antagonists Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Angiotensin Receptor Antagonists Sales Market Share by Type in 2022 & 2034
Figure 19. North America Angiotensin Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 20. North America Angiotensin Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 21. Europe Angiotensin Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 22. Europe Angiotensin Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 25. Latin America Angiotensin Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Angiotensin Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Receptor Antagonists Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Receptor Antagonists Revenue in 2022
Figure 31. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hypertension
Figure 33. Global Hypertension Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Product Picture of Cardiovascular Diseases
Figure 35. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K MT)
Figure 36. Product Picture of Kidney Diseases
Figure 37. Global Kidney Diseases Sales YoY Growth (2018-2034) & (K MT)
Figure 38. Product Picture of Other
Figure 39. Global Other Sales YoY Growth (2018-2034) & (K MT)
Figure 40. Global Angiotensin Receptor Antagonists Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Angiotensin Receptor Antagonists Sales Market Share by Application in 2022 & 2034
Figure 42. North America Angiotensin Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 43. North America Angiotensin Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 44. Europe Angiotensin Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 45. Europe Angiotensin Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 48. Latin America Angiotensin Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Angiotensin Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Angiotensin Receptor Antagonists Manufacturing Cost Structure
Figure 53. Angiotensin Receptor Antagonists Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries